April, 2021

article thumbnail

GDPR represents an “urgent threat” to the EU’s research leadership role

pharmaphorum

More than 5,000 collaborative studies were thwarted by GDPR rules in 2019 – but is there a way to protect sensitive data while still allowing international health research to thrive? . A coalition of European academy networks has called upon European Union (EU) leaders to rethink how General Data Protection Regulation (GDPR) rules are applied to health data.

140
140
article thumbnail

Thermo Fisher Scientific snaps up PPD in $17.4b acquisition deal

Outsourcing Pharma

The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed.

115
115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

8 amlodipine alternative drugs for blood pressure

Druggist

Amlodipine is one of the most commonly prescribed drugs in the UK and the most prescribed high blood pressure ( BP ) medication. When patients are diagnosed with high blood pressure and a drug is recommended, amlodipine may be the first choice, but not always. Taking any drugs comes with a risk of side effects, with amlodipine associated with few common side effects.

article thumbnail

Introducing the 2020-21 HBA Honorable Mentor and STAR Awardees

Pharma Marketing Network

Introducing the recipient of the 2020-21 HBA Honorable Mentor Award, Dr. Rod MacKenzie , Chief Development Officer and EVP, Pfizer and the recipient of the 2020-21 HBA STAR Award, Susan Torroella , Chief Operating Officer, ArmadaHealth. What is the Honorable Mentor Award? The Honorable Mentor award recognizes a man who demonstrates a long-term commitment to advancing women in the workforce, is dedicated to developing, mentoring and promoting women in the industry, and is supportive of the overal

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Care … Amazon’s Revolutionary Move into Healthcare

Fuld

In just three years, Amazon has put together a package of leading-edge services that have the potential to revolutionize the US healthcare market. The major global brand is now maximizing the use of technology to allow patients to continue to use telemedicine to interact with providers on their time and in their preferred location. It is delivering prescriptions to patients rather than forcing them to go to a retail pharmacy, and it is providing a low-cost, hi-tech 24/7 on-body monitoring servic

article thumbnail

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Pharma Mirror

Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.

52

More Trending

article thumbnail

Canine cancer research startup impacts treatment in humans

Outsourcing Pharma

One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

114
114
article thumbnail

Apixaban vs warfarin: rise of newer anticoagulant

Druggist

Apixaban (Eliquis®) and warfarin are two popular prescription-only drugs classified as anticoagulants, commonly known as blood thinners. Warfarin has been used as an anticoagulant for a very long time. However, in recent years warfarin’s popularity decreased in place of newer anticoagulants such as apixaban, as reflected by prescribing statistics.

Dosage 98
article thumbnail

6 Digital Tools at the Center of Healthcare Digitalization [INFOGRAPHIC]

Pharma Marketing Network

Over the last year, we witnessed a massive shift to digital technologies in the health industry – trends that were gradually making their ways suddenly moved into prompt adoption due to the immense limitations brought by the COVID-19 pandemic. Download this infographic and learn which 6 digital tools are at the center of digitalization and how the will influence the future of Pharma marketing in 2021 and beyond.

article thumbnail

Take the next step into CROY 2021

Pharma Times

The 2021 Clinical Researcher of the Year – The Americas competition is reaching out to the very best in the industry to take the next step and claim gold.

48
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

AavantiBio and Catalent Announce Partnership to Support Development and Manufacturing of Gene Therapies for Rare Genetic Diseases

Pharma Mirror

AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies, including its lead program in Friedreich’s Ataxia (FA).

52
article thumbnail

Apple, Google block NHS contact tracing app update on privacy grounds

pharmaphorum

A scheduled update to the NHS COVID-19 app has been blocked because it allows location tracking – something prohibited by Apple and Google, which developed some of the code it uses. . The new version of the app used in England and Wales was due to become available today to coincide with the relaxation of lockdown rules, with the public now able to attend venues such as non-essential shops, pub beer garden, gyms and hairdressers.

138
138
article thumbnail

Study explores synthetic cannabinoid for cancer-related anorexia

Outsourcing Pharma

Artelo Biosciences is investigating the viability of its novel cannabinoid product as a solution to treat cancer-related anorexia in oncology patients.

96
article thumbnail

Best throat numbing lozenges | Get rid of sore throat

Druggist

For many customers, throat numbing lozenges are the first choice in the management of sore and irritated throat. Throat numbing lozenges contain a local anaesthetic which numbs the area and hence help with pain and irritation. This post list all sore throat lozenges containing a local anaesthetic available in the UK. You may also be interested in a related post listing variety of sore throat lozenges.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Protected: Health Psychology – the Solution to First Fill Abandonment?

Pharma Marketing Network

This content is password protected. To view it please enter your password below: Password: The post Protected: Health Psychology – the Solution to First Fill Abandonment? appeared first on Pharma Marketing Network.

96
article thumbnail

Amylyx Pharma plans to file ALS therapy with the EMA this year

Pharma Times

The previously-reported CENTAUR study of AMX0035 in 137 participants with ALS met its primary endpoint of slowing ALS progression

49
article thumbnail

CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted

Pharma Mirror

Tokyo 27th April 2021: CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe. The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In fact, such has been the demand, CPhI Japan Connect – the event’s digital platform for international audiences – will remain open until the end of May.

52
article thumbnail

Is disability the last bastion of the representation debate?

pharmaphorum

From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.

article thumbnail

Berg taps into supercomputer to battle COVID-19 variants

Outsourcing Pharma

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations.

98
article thumbnail

Best Lacri-Lube alternative eye ointments

Druggist

Lacri-lube has been out of stock for months. Still, after all this time, some patients get repeat prescriptions issued with Laci-Lube on it. Patients who have Lacri-Lube eye ointment on their ‘repeats’ should contact their surgery and ask to remove it and replace it with Lacri-lube alternative eye ointments. I will list in this post the best Lacri-Lube alternative eye ointments and gels.

93
article thumbnail

DarshanTalks: Sales & Marketing Oversight – April 21, 2021

Pharma Marketing Network

[link]. The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the life sciences. Sales and marketing representatives in the life science industry must comply with state and federal regulations.

90
article thumbnail

Magic mushroom compound psilocybin shows ‘promise’ in depression

Pharma Times

Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting

article thumbnail

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields

Pharma Mirror

Scivita Medical Technology Co., Ltd. (“Scivita Medical”) announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment.

52
article thumbnail

Digital tool will be tested against COVID-19 ‘brain fog’

pharmaphorum

A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.

Hospitals 127
article thumbnail

Cyclica teams with academics to investigate COVID-19 treatment

Outsourcing Pharma

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatmentâs potential in treating COVID-19.

97
article thumbnail

Diltiazem cream: uses, side effects and availability

Druggist

Diltiazem cream (diltiazem hydrochloride cream) is a medicine prescribed in the UK to manage chronic anal fissure. Today I will answer the most common questions surrounding the use, availability and treatment with this cream. Summary: What is diltiazem cream used for? How does diltiazem help with anal fissures? Classification of anal fissures. The legal classification of topical diltiazem .

81
article thumbnail

Key Sessions From the AI in Healthcare Virtual Summit

Pharma Marketing Network

The AI in Healthcare Virtual Summit focused on AI methods and tools that are set to transform healthcare, medicine, and diagnostics along with the latest applications within the industry. . Here are some key sessions during the summit that discussed machine learning for antibiotic discovery, creating personalized neuro medicine using AI and brain modelling, and deep learning for biomedical imaging.

article thumbnail

Calling all pharma marketers

Pharma Times

The 2021 Marketer of the Year competition is well underway for entries and is looking for the best and brightest to join the ranks.

45
article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.

Hospitals 122
article thumbnail

AI is having a productive time in pharma and healthcare

pharmaphorum

Two years ago the use of AI in pharma and healthcare looked to be quickly heading for what Gartner’s Hype Cycle model would term the Plateau of Productivity. After the COVID-powered digital transformations of both pharma and healthcare , there can be little doubt that artificial intelligence is already having a productive time across our sector. It could even be, as consultants GlobalData predicted back in January, this year’s most disruptive technology across the pharmaceutical industry, though

FDA 114
article thumbnail

Exscientia starts trials of first AI-derived cancer immunotherapy

pharmaphorum

Exscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) last year, and now says it has started testing of the first AI candidate for immuno-oncology. . Oxford, UK-based Exscientia has been working with German biotech Evotec on the adenosine A2a receptor antagonist, which is being tested as a treatment for adult patients with advanced solid tumours.

article thumbnail

The power of communication: engaging diverse groups in healthcare

pharmaphorum

Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society – especially in healthcare. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected.

article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. . The cost-effectiveness agency has said that anti-CD20 antibody Kesimpta (ofatumumab) can be prescribed via the NHS in England and Wales as a treatment for adults with RMS with active disease, as either a first-line therapy or after alternative drugs have been tried.

Hospitals 111
article thumbnail

Magic mushroom compound matches antidepressant in clinical trial

pharmaphorum

The active compound in magic mushrooms – psilocybin – seems to be at least as effective as a commercially-available antidepressant in a phase 2 trial, and may work more quickly. . Researchers at Imperial College London’s Centre for Psychedelic Research also say that psilocybin may have a stronger effect and was more likely to help patients achieve remission from depression, although they stress the study was small and more research is needed.